review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM199005033221805 |
P698 | PubMed publication ID | 2271017 |
P2093 | author name string | Harris ED Jr | |
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
pathophysiology | Q1135939 | ||
P304 | page(s) | 1277-1289 | |
P577 | publication date | 1990-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Rheumatoid arthritis. Pathophysiology and implications for therapy | |
P478 | volume | 322 |
Q93937195 | Q93937195 |
Q43687760 | 7,3'-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis |
Q44480293 | A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities |
Q26823326 | A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis |
Q41897952 | A locum experience in rural Alberta. |
Q38628540 | A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study |
Q28366568 | A phase II trial of marimastat in advanced pancreatic cancer |
Q43184375 | A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis |
Q71970888 | A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis |
Q40932806 | A review on the strategies for the development and application of new anti-arthritic agents |
Q24816463 | A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example |
Q34283353 | A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases |
Q67904350 | Activated, cytotoxic lymphocytes in systemic vasculitis |
Q33912667 | Activation of gammadelta T cells by mycobacterial antigens in rheumatoid arthritis |
Q81521829 | Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway |
Q53262191 | Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis. |
Q28214227 | Active site residues of cyclophilin A are crucial for its signaling activity via CD147 |
Q24792231 | Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue |
Q54339705 | Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy. |
Q45739253 | Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis |
Q34172735 | Adenoviral-mediated gene transfer to rabbit synovium in vivo. |
Q34156535 | Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature |
Q41133422 | Adhesion molecules in autoimmune disease |
Q28219228 | Adult onset Still's disease: review of 26 cases |
Q40434105 | Advances and issues in the pharmacotherapy of rheumatoid arthritis |
Q24234197 | Adverse effects of biologics: a network meta-analysis and Cochrane overview |
Q24235218 | Adverse effects of biologics: a network meta-analysis and Cochrane overview |
Q43800686 | Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products |
Q45830734 | An immunological biomarker to predict MTX response in early RA. |
Q73429745 | An in vitro Model for Studying Mechanisms Underlying Synoviocyte-Mediated Cartilage Invasion in Rheumatoid Arthritis |
Q41915136 | An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis |
Q43061720 | Anakinra in the treatment of rheumatic disease |
Q36627709 | Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages |
Q34989354 | Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. |
Q24816803 | Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis |
Q37288716 | Anti-angiogenic effect of total saponins of Rhizoma Dioscorea nipponica on collagen induced-arthritis in rats |
Q51421445 | Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats. |
Q36281697 | Anti-arthritic property of crude extracts of Piptadeniastrum africanum (Mimosaceae) in complete Freund's adjuvant-induced arthritis in rats |
Q86822995 | Anti-inflammatory and anti-arthritic effects of Guge Fengtong Formula: in vitro and in vivo studies |
Q35258478 | Anti-inflammatory drugs in the treatment of allergic disease |
Q40845933 | Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis |
Q33605248 | Antibiotics for rheumatoid arthritis? Minocycline shows promise in some patients |
Q41465391 | Antigen-presenting capacity of rheumatoid synovial fibroblasts. |
Q73000841 | Application of murine T-T hybridoma cells to in vitro potency assay of human synthetic peptide vaccines |
Q40325293 | Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. |
Q35210279 | Arthritis and related diseases of the foot and ankle: rehabilitation and biomechanical considerations |
Q41335748 | Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes |
Q67753781 | Articular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activity |
Q38132000 | Aryl hydrocarbon receptor and experimental autoimmune arthritis |
Q36891043 | Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis |
Q35180584 | Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis |
Q28218270 | Aspirin-induced apoptosis in human gastric cancer epithelial cells: relationship with protein kinase C signaling |
Q28171138 | Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism |
Q33350273 | Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism |
Q30836373 | Assessment of proximal finger joint inflammation in patients with rheumatoid arthritis, using a novel laser-based imaging technique |
Q38168734 | Association between TNF-α promoter -308 A/G polymorphism and rheumatoid arthritis: a meta-analysis |
Q50972447 | Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis : A meta-analysis. |
Q57330130 | Association between shortened telomere length and rheumatoid arthritis : A meta-analysis |
Q53093196 | Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis. |
Q37545692 | Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis |
Q57330540 | Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis |
Q40084891 | Association of Asthma with Rheumatoid Arthritis: A Population-Based Case-Control Study |
Q36565844 | Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis |
Q34893105 | Association of interleukin-18 (-137G/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis |
Q30252113 | Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis. |
Q83257758 | Association of the C-285T and A5954G polymorphisms in the DNA repair gene OGG1 with the susceptibility of rheumatoid arthritis |
Q56897602 | Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population |
Q38807451 | Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis |
Q57330622 | Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis |
Q53107516 | Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. |
Q37994655 | Associations between the p53 codon 72 polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis |
Q57330649 | Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis |
Q90401583 | Attenuation of Rheumatoid Inflammation by Sodium Butyrate Through Reciprocal Targeting of HDAC2 in Osteoclasts and HDAC8 in T Cells |
Q28377542 | Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes |
Q77079974 | Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3 |
Q44189195 | Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis |
Q36361368 | Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients |
Q41122312 | Beta-endorphin and the immune system--possible role in autoimmune diseases |
Q34207030 | Biochemical markers to survey bone turnover |
Q34074934 | Biological agents: a novel approach to the therapy of rheumatoid arthritis |
Q24816745 | Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review |
Q24240891 | Biologics for rheumatoid arthritis: an overview of Cochrane reviews |
Q77909420 | Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha |
Q33584114 | Bone resorption by cells isolated from rheumatoid synovium |
Q36702456 | Bridging Clinical Outcomes of Canakinumab Treatment in Patients With Rheumatoid Arthritis With a Population Model of IL-1β Kinetics |
Q40543143 | Broad Infiltration of Macrophages Leads to a Proinflammatory State in Streptozotocin-Induced Hyperglycemic Mice. |
Q35126948 | C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis |
Q22010750 | CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
Q54170357 | CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis. |
Q51799490 | CD147 promotes IKK/IκB/NF-κB pathway to resist TNF-induced apoptosis in rheumatoid arthritis synovial fibroblasts. |
Q48035841 | CD28 co-stimulation is intact and contributes to prolonged ex vivo survival of hyporesponsive synovial fluid T cells in rheumatoid arthritis |
Q37354502 | CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity |
Q35160039 | CD5 Negative IGM Rheumatoid Factor B Cells in B-Chronic Lymphocytic Leukemia and Benign Mixed Cryoglobulinemia |
Q48511100 | CMNSG Guest Lecture. Interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist |
Q57232012 | CXCR2‐specific chemokines mediate leukotriene B4–dependent recruitment of neutrophils to inflamed joints in mice with antigen‐induced arthritis |
Q41101813 | Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints |
Q38161548 | Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? |
Q51046090 | Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. |
Q33565954 | Can immunisation trigger rheumatoid arthritis? |
Q37277626 | Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis |
Q35547065 | Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction |
Q24562315 | Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism |
Q74030201 | Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis |
Q80268553 | Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant |
Q35539225 | Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ |
Q41180587 | Cellular and molecular analysis of lymphoid development using Rag-deficient mice |
Q39308974 | Cellular and molecular perspectives in rheumatoid arthritis |
Q79303236 | Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts |
Q40779591 | Characterization of a human synovial cell antigen: VCAM-1 and inflammatory arthritis |
Q71081690 | Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83 |
Q42153753 | Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). |
Q72180817 | Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells |
Q36579912 | Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys |
Q34296506 | Chemokines in immunity |
Q77627727 | Chemokines in rheumatoid arthritis |
Q44869580 | Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins |
Q53113304 | Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias. |
Q51135653 | Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. |
Q30251936 | Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. |
Q89304727 | Clindamycin Administration Increases the Incidence of Collagen-Induced Arthritis in Mice Through the Prolonged Impact of Gut Immunity |
Q33807697 | Clinical characteristics of rheumatoid arthritis patients undergoing cervical spine surgery: an analysis of National Database of Rheumatic Diseases in Japan |
Q36098699 | Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein |
Q36243965 | Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan |
Q52710782 | Clinical utility of eco-color-power Doppler ultrasonography and contrast enhanced magnetic resonance imaging for interpretation and quantification of joint synovitis: a review. |
Q36361765 | Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients |
Q24792089 | Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis |
Q52199399 | Cloning and developmental expression of a membrane-type matrix metalloproteinase from chicken. |
Q39922847 | Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin |
Q57330333 | Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis |
Q37263440 | Combination chemotherapy in rheumatoid arthritis |
Q64074628 | Comparative Evaluation of Ga-Citrate PET/CT and F-FDG PET/CT in the Diagnosis of Type II Collagen-Induced Arthritis in Rats |
Q38675968 | Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controll |
Q50910994 | Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. |
Q57330076 | Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis |
Q37689953 | Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients |
Q55177710 | Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing d |
Q39109424 | Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. |
Q48213354 | Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity. |
Q37240538 | Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis |
Q42049241 | Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. |
Q45006569 | Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid arthritis: assessment of therapeutic response |
Q38894091 | Control of autoimmune inflammation by celastrol, a natural triterpenoid |
Q39008809 | Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis |
Q42878305 | Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA? |
Q34001060 | Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis |
Q35822124 | Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides |
Q34132261 | Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. |
Q40490594 | Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders |
Q35233161 | Cytokine abnormalities in inflammatory arthritis |
Q33565984 | Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis |
Q36287536 | Cytokine signal regulation and autoimmune disorders |
Q34252489 | Cytokine-mediated bone destruction in rheumatoid arthritis |
Q48027852 | Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention |
Q41552289 | Daily oral administration of low-dose methotrexate has greater antirheumatic effects in collagen-induced arthritis rats |
Q34152068 | Defining the genetic origins of three rheumatoid synovium-derived IgG rheumatoid factors |
Q38648496 | Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritis. |
Q40985205 | Detection of TNF alpha and Fas ligand mRNA within synovial mononuclear cells by fluorescence in-cell labeling PCR (FICL-PCR). |
Q51392512 | Detection of new epitopes of antibodies to filaggrin in filaggrin protein molecule. |
Q74187188 | Development of anti-TNF therapy for rheumatoid arthritis |
Q81346281 | Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease |
Q54333033 | Different apoptotic responses of RA synoviocytes depending on different genotypes of the mdm2 SNP T309G. |
Q44040769 | Differential diagnosis of rheumatoid granuloma |
Q43413202 | Differential expression of U2AF35 in the arthritic joint of avian reovirus-infected chicks |
Q52820177 | Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity. |
Q28379596 | Discovery and analysis of inflammatory disease-related genes using cDNA microarrays |
Q37799060 | Disease-modifying antirheumatic and immunoregulatory agents |
Q42103357 | Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion |
Q47815824 | Does practice mirror the evidence base in the treatment of rheumatoid arthritis? |
Q34158788 | Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis |
Q50268454 | Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases |
Q40493960 | Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation |
Q46470525 | Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine |
Q81356317 | Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model |
Q40799823 | Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome |
Q71549301 | Effect of IL-10 on collagen-induced arthritis in mice |
Q35163074 | Effect of MPG gene rs2858056 polymorphism, copy number variation, and level of serum MPG protein on the risk for rheumatoid arthritis |
Q73938546 | Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages |
Q46833110 | Effect of estrogen replacement therapy on arthritis and bone mineral density in estrogen-replete rats with collagen-induced arthritis |
Q36334937 | Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model. |
Q60912117 | Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial |
Q39967125 | Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells |
Q41392263 | Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes |
Q39085635 | Effects of Ureaplasma urealyticum lipid-associated membrane proteins on rheumatoid arthritis synovial fibroblasts |
Q78053671 | Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells |
Q74095902 | Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis |
Q57330038 | Efficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritis |
Q38250318 | Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials |
Q48017228 | Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts |
Q40823594 | Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis |
Q45745775 | Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1). |
Q24812727 | Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel' |
Q34108064 | Emerging roles of SUMO modification in arthritis |
Q41525992 | Emerging treatments for rheumatoid arthritis |
Q42123220 | Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes |
Q45878993 | Engineering dynamics of growth factors and other therapeutic ligands |
Q41654281 | Establishing a research agenda for investigating alternative medical interventions for chronic pain |
Q50906970 | Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra. |
Q30990338 | Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model |
Q48562919 | Evaluation of the association of UBASH3A and SYNGR1 with rheumatoid arthritis and disease activity and severity in Han Chinese |
Q28577098 | Evidence for cyclooxygenase-2 association with caveolin-3 in primary cultured rat chondrocytes |
Q73165873 | Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis |
Q34121006 | Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis |
Q38651509 | Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes |
Q77794736 | Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls |
Q35083265 | Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis |
Q72792611 | Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients |
Q34121541 | Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature |
Q58064608 | Expression and functional significance of an activation-dependent epitope of the beta 1 integrins in chronic inflammatory diseases |
Q28268576 | Expression and functions of very late antigen 1 in inflammatory joint diseases |
Q56943278 | Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) |
Q47399907 | Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation |
Q53519864 | Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. |
Q45765388 | Expression of TNF alpha in arthritis caused by caprine arthritis encephalitis virus |
Q47776925 | Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis |
Q73792147 | Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice |
Q33566999 | Expression of ectopeptidases in scleroderma |
Q72611596 | Expression of endogenous retroviruses, ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis |
Q35786887 | Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway |
Q37403761 | Expression of tyrosine hydroxylase in CD4+ T cells contributes to alleviation of Th17/Treg imbalance in collagen-induced arthritis |
Q33639413 | Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats |
Q47348590 | Extracts of Arisaema rhizomatum C.E.C. Fischer attenuate inflammatory response on collagen-induced arthritis in BALB/c mice |
Q36896228 | Extracts of Tripterygium wilfordii Hook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled Trials |
Q37896132 | FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. |
Q39976969 | FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis |
Q84428116 | Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis |
Q57330337 | Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis |
Q70497558 | Functions of polymorphonuclear leukocytes in early rheumatoid arthritis |
Q35682550 | Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta-analysis |
Q39711491 | Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy |
Q38195131 | Gene-environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis |
Q36231063 | Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response |
Q59335681 | Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion |
Q40927315 | Genetic background and environment contribute synergistically to the onset of autoimmune diseases |
Q37370648 | Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis |
Q82792244 | Genetic polymorphisms of the DNA repair gene UNG are associated with the susceptibility of rheumatoid arthritis |
Q44619333 | Genetic polymorphisms of the DNA repair geneMPG may be associated with susceptibility to rheumatoid arthritis |
Q35882362 | Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. |
Q58719858 | Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients |
Q57330550 | Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis |
Q24240895 | Golimumab for rheumatoid arthritis |
Q56212157 | Guidelines for the management of rheumatoid arthritis: 2002 Update |
Q37313157 | Hepatic vitamin A preloading reduces colorectal cancer metastatic multiplicity in a mouse xenograft model |
Q71641038 | High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice |
Q70823380 | High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints |
Q33683442 | Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis |
Q46767224 | Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis |
Q24806177 | Homing chemokines in rheumatoid arthritis. |
Q34222528 | Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis |
Q72417264 | How could infectious agents hide in synovial cells? Possible mechanisms of persistent viral infection in a model for the etiopathogenesis of chronic arthritis |
Q48628101 | How kinematic disturbance in the deformed rheumatoid thumb impacts on hand function: a biomechanical and functional perspective |
Q38689030 | Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women's Health Initiative Rheumatoid Arthritis Study |
Q24293134 | Human cyclooxygenase-2 cDNA |
Q30442868 | Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb |
Q33665370 | Hypochlorite-induced structural modifications enhance the chaperone activity of human α2-macroglobulin |
Q43775035 | Hypoxia-induced endogenous prostaglandin E2 negatively regulates hypoxia-enhanced aberrant overgrowth of rheumatoid synovial tissue |
Q72873797 | IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells |
Q44221482 | IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models |
Q42963596 | Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation |
Q37352795 | Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay |
Q36292289 | Identification of α1-Antitrypsin as a Potential Candidate for Internal Control for Human Synovial Fluid in Western Blot |
Q38434343 | Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis |
Q41384865 | IgH and L chain variable region gene sequence analyses of twelve synovial tissue-derived B cell lines producing IgA, IgG, and IgM rheumatoid factors structure/function comparisons of antigenic specificity, V gene sequence, and Ig isotype. |
Q67792108 | Imbalanced cytokine production by macrophages from autoimmune-prone mice |
Q34129750 | Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system |
Q30942899 | Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes |
Q48521265 | Immunohistology of the early course of lentivirus-induced arthritis. |
Q33566911 | Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis |
Q33898784 | Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium |
Q39259474 | Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines |
Q35798176 | Immunopathology of chronic lentivirus-induced arthritis |
Q42942352 | Immunoregulatory role of interleukin 10 in rheumatoid arthritis |
Q92761515 | Impact of Hemodialysis on Surgical Outcomes and Mortality Rate after Lumbar Spine Surgery: A Matched Cohort Study |
Q73486207 | In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum |
Q38824483 | In vivo antiarthritic activity of the ethanol extracts of stem bark and seeds of Calophyllum inophyllum in Freund's complete adjuvant induced arthritis |
Q56998712 | In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis |
Q34002641 | Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. |
Q48030951 | Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy |
Q41019786 | Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). |
Q54069737 | Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell. |
Q36367259 | Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients |
Q24799278 | Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis |
Q36815633 | Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis |
Q50902036 | Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. |
Q74242404 | Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts |
Q52882153 | Induction of proliferation and pro-inflammatory cytokine production in rheumatoid arthritis peripheral blood mononuclear cells by a 65 KDa chondrocyte membrane-specific, constitutive target autoantigen (CH65). |
Q34219694 | Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results |
Q36627704 | Influence of sensitization and allergen provocation procedures on the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs |
Q38337604 | Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes |
Q35846015 | Inhibitory Effect of Curcumol on Jak2-STAT Signal Pathway Molecules of Fibroblast-Like Synoviocytes in Patients with Rheumatoid Arthritis |
Q77849071 | Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells |
Q73519432 | Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis |
Q40963925 | Innovative treatment approaches for rheumatoid arthritis. Combination therapy |
Q36721408 | Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases |
Q72737439 | Interactions between lymphocytes and type A synoviocytes in rheumatoid synovium |
Q35610493 | Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth |
Q24793971 | Interferon-beta for treatment of rheumatoid arthritis? |
Q34344877 | Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas |
Q77118254 | Interleukin-1 receptor antagonist |
Q72209825 | Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts |
Q34224384 | Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis |
Q80066395 | Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis |
Q53368699 | Interleukin-18, interleukin-12B and interferon-γ gene polymorphisms in Brazilian patients with rheumatoid arthritis: a pilot study. |
Q72370429 | Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes |
Q74046787 | Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cells |
Q34047753 | Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications |
Q30804224 | Interpreting radiographic data in rheumatoid arthritis |
Q26799587 | Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications |
Q73779683 | Intracerebroventricular administration of somatostatin prevents and attenuates adjuvant arthritis |
Q33566324 | Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane |
Q41936911 | Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience. |
Q45751487 | Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene |
Q28202653 | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis |
Q35548076 | Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis |
Q36405454 | Involvement of the p38 MAPK-NF-kappaB signal transduction pathway and COX-2 in the pathobiology of meniscus degeneration in humans |
Q89687402 | Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? |
Q51850819 | Isolation, characterization, and molecular modeling of a rheumatoid factor from a Hepatitis C virus infected patient with Sjögren's syndrome. |
Q72035924 | Joint-derived T cells in rheumatoid arthritis react with self-immunoglobulin heavy chains or immunoglobulin-binding proteins that copurify with immunoglobulin |
Q35549454 | Labour force participation among patients with rheumatoid arthritis |
Q33186401 | Lead discovery of alpha,beta-unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expression |
Q70774525 | Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage |
Q35553944 | Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis |
Q80387959 | Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes |
Q33567681 | Local immune responses in certain extra-articular manifestations of rheumatoid arthritis |
Q47186021 | Logistic regression analysis of damp-heat and cold-damp impeding syndrome of rheumatoid arthritis: a perspective in Chinese medicine |
Q33567294 | Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines |
Q37321296 | Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. |
Q49460237 | Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis |
Q35438412 | Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients |
Q45924953 | Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. |
Q33764981 | Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise |
Q84629936 | MBD4 gene is associated with rheumatoid arthritis in Chinese patients in Taiwan |
Q67844670 | MRI of knee arthritis in rheumatoid arthritis and spondylarthropathies |
Q71446692 | Mac-1 (CD11b/CD18) is the predominant beta 2 (CD18) integrin mediating human neutrophil migration through synovial and dermal fibroblast barriers |
Q35548569 | Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis |
Q35548454 | Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement |
Q39467334 | Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities |
Q33929261 | Management of rheumatic diseases in children |
Q40393577 | Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications |
Q34655385 | Matrix metalloproteinases and atherosclerotic plaque instability |
Q53067063 | Mechanism of the 24-hour rhythm of tumor necrosis factor-alpha formed by onset of rheumatoid arthritis. |
Q79319433 | Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy |
Q42233700 | Meta-analysis of gene expression profiles to predict response to biologic agents in rheumatoid arthritis |
Q38612492 | Meta-analysis of the association between PADI4 -92C/G polymorphism and rheumatoid arthritis in the Chinese population |
Q35182959 | Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives? |
Q73526256 | Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis |
Q40878401 | Methotrexate use in rheumatoid arthritis |
Q72863111 | Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay |
Q77118216 | Minocycline for the treatment of rheumatoid arthritis |
Q77385596 | Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA) |
Q44464626 | Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. |
Q70978774 | Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta |
Q48168200 | Molecular analysis of the V kappa III-J kappa junctional diversity of polyclonal rheumatoid factors during rheumatoid arthritis frequently reveals N addition |
Q40901167 | Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? |
Q40458464 | Molecular/cell engineering approach to autocrine ligand control of cell function. |
Q46447012 | N-(2-hydroxy phenyl) acetamide produces profound inhibition of c-Fos protein and mRNA expression in the brain of adjuvant-induced arthritic rats. |
Q50848109 | N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis. |
Q58703927 | Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome |
Q33668883 | New therapeutic targets for rheumatoid arthritis |
Q33758853 | New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs |
Q34585191 | Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy |
Q34941147 | Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice |
Q34242689 | Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation |
Q43679819 | Nitrobenzene compounds inhibit expression of VCAM-1. |
Q47280887 | No relationship of -627 interleukin-10 promoter polymorphism in Chinese patients with rheumatoid arthritis |
Q52868140 | Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent. |
Q45866599 | Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes |
Q36623081 | Novel therapies for rheumatoid arthritis |
Q47702773 | Nuclear factor-κB regulates RANTES chemokine expression in response to tumor necrosis factor-α in fibroblast-like synoviocytes |
Q39110118 | Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence |
Q41525983 | Office evaluation of the patient with musculoskeletal complaints |
Q73313502 | Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints |
Q71548688 | Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells |
Q42022447 | Optimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts. |
Q46125639 | Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis |
Q35834016 | Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. |
Q73554846 | Orthopaedic surgery in the elderly |
Q36284324 | Osler-as much heart as head: The importance of compassion |
Q35602113 | Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy |
Q73943189 | Oxidant stress and essential fatty acids in patients with risk and established ARDS |
Q37726242 | PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients |
Q79693938 | PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis |
Q46677052 | PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis |
Q33542907 | Pain in the rheumatic diseases. Practical aspects of diagnosis and treatment |
Q35763598 | Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. |
Q67756849 | Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy |
Q37287492 | Parasitic infection as a potential therapeutic tool against rheumatoid arthritis |
Q42648866 | Pathogenesis of rheumatoid arthritis |
Q36647506 | Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s |
Q34275992 | Pathogenesis of rheumatoid arthritis: the role of synoviocytes |
Q41124906 | Pathways of coagulation activation in situ in rheumatoid synovial tissue |
Q35780350 | Patient-reported outcomes and their role in the assessment of rheumatoid arthritis |
Q80789744 | Pedobarography and its relation to radiologic erosion scores in rheumatoid arthritis |
Q36786958 | Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis |
Q77995177 | Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid |
Q35788500 | Pharmacological and therapeutic effects of A3 adenosine receptor agonists |
Q92055384 | Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice |
Q24803862 | Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis |
Q40874634 | Phospholipase A2 and arthritis |
Q67862507 | Photopheresis for Rheumatoid Arthritis |
Q46860163 | Physicochemical characterization, in vitro, and in vivo evaluation of indomethacin-loaded nanocarriers self-assembled by amphiphilic polyphosphazene. |
Q90645966 | Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity |
Q38411740 | Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis |
Q36893636 | Positional cloning of the Igl genes controlling rheumatoid factor production and allergic bronchitis in rats |
Q46281335 | Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis |
Q73904133 | Postural sway characteristics in women with lower extremity arthritis before and after an aquatic exercise intervention |
Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
Q30500520 | Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience |
Q40947088 | Prevalence of total knee arthroplasty and its predictive factors in Japanese patients with rheumatoid arthritis: Analysis using the NinJa cohort |
Q73958667 | Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor |
Q68143609 | Production of interleukin 8 by cultured synovial cells in response to interleukin 1 and tumor necrosis factor |
Q36820854 | Prognostic staging for therapy of rheumatoid arthritis |
Q43524051 | Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis |
Q73580692 | Prospective X-ray densitometry and ultrasonography study of the hand bones of patients with rheumatoid arthritis of recent onset |
Q34915258 | Protective effect of low-level laser therapy (LLLT) on acute zymosan-induced arthritis |
Q37067664 | Protective efficacy of N-(2-hydroxyphenyl) acetamide against adjuvant-induced arthritis in rats |
Q40435435 | Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells. |
Q41151376 | Psychiatric aspects of rheumatology |
Q40512470 | Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex |
Q42754849 | Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. |
Q38991582 | Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis |
Q52689527 | Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease. |
Q35547547 | Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus |
Q35554244 | Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description |
Q39199564 | Relationship between roentgenographic joint destruction in the hands and functional disorders among patients with rheumatoid arthritis. |
Q53540861 | Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis. |
Q39012595 | Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis |
Q53733301 | Relevance of P-glycoprotein on CXCR4+ B cells to organ manifestation in highly active rheumatoid arthritis. |
Q38416292 | Repeated Electroacupuncture Persistently Elevates Adenosine and Ameliorates Collagen-Induced Arthritis in Rats |
Q80219025 | Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies |
Q28763569 | Reproductive failure and the major histocompatibility complex |
Q44512203 | Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis |
Q35645344 | Resurfacing shoulder arthroplasty for the treatment of severe rheumatoid arthritis: outcome in 167 patients from the Danish Shoulder Registry. |
Q47201692 | Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data. |
Q46455430 | Rheumatoid arthritis in south-east Europe |
Q37630862 | Rheumatoid arthritis. New developments in treatment |
Q40972189 | Rheumatoid arthritis: pathogenesis and early recognition |
Q24792902 | Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells |
Q70172084 | Rheumatology |
Q38813214 | Role of CX3CL1 in Diseases |
Q39362038 | Role of Gut Microbiota in Rheumatoid Arthritis |
Q37008658 | Role of Txk, a member of the Tec family of tyrosine kinases, in immune-inflammatory diseases |
Q35753906 | Role of basophils in rheumatoid arthritis (Review). |
Q33578981 | Role of enteric bacteria in the pathogenesis of rheumatoid arthritis: evidence for antibodies to enterobacterial common antigens in rheumatoid sera and synovial fluids |
Q34428921 | Role of macrophage CCAAT/enhancer binding protein delta in the pathogenesis of rheumatoid arthritis in collagen-induced arthritic mice. |
Q28181734 | Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells |
Q54475391 | Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. |
Q60924007 | SPACIA1/SAAL1 Deletion Results in a Moderate Delay in Collagen-Induced Arthritis Activity, along with mRNA Decay of Gene |
Q30891297 | Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries |
Q33575269 | Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis |
Q72174617 | Scleritis associated with systemic vasculitic diseases |
Q47947411 | Secretory sphingomyelinase (S-SMase) activity is elevated in patients with rheumatoid arthritis |
Q30563974 | Seeing the forest despite the trees. The benefit of exploratory data analysis to program evaluation research |
Q35876782 | Selective IgA deficiency in autoimmune diseases |
Q44114291 | Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis |
Q71118266 | Selective inhibition of interleukin-1 beta gene expression in activated RAW 264.7 macrophages by interferon-gamma |
Q36476632 | Serum Copper as a Marker of Disease Activity in Rheumatoid Arthritis |
Q72580328 | Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis |
Q67992449 | Serum N terminal procollagen III fragment: a predictive marker of joint destruction in rheumatoid arthritis? |
Q74582450 | Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three-colour flow cytometry |
Q33564477 | Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis |
Q35752432 | Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals |
Q44815231 | Somatostatin analogue treatment attenuates histological findings of inflammation and increases mRNA expression of interleukin-1 beta in the articular tissues of rats with ongoing adjuvant-induced arthritis |
Q40799982 | Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase. |
Q35549487 | Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed |
Q42713846 | Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium |
Q27730830 | Structure and mechanism of interleukin-1 beta converting enzyme |
Q37365012 | Studies on the contribution of c-fos/AP-1 to arthritic joint destruction |
Q35954629 | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab |
Q37089685 | Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi |
Q40432257 | Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis |
Q90654702 | Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission |
Q45864343 | Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy |
Q34219054 | Suppression of ongoing experimental arthritis by a chinese herbal formula (huo-luo-xiao-ling dan) involves changes in antigen-induced immunological and biochemical mediators of inflammation. |
Q39185906 | Survey on attitudes regarding EULAR recommendations for the role of nurses involved in medical care of patients with chronic inflammatory arthritis in Japan |
Q37207090 | Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent |
Q34158420 | Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis |
Q71739888 | Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation |
Q53562795 | Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients. |
Q39708042 | Synovial tissue hypoxia and inflammation in vivo |
Q33566039 | Synovial tissue macrophages and joint erosion in rheumatoid arthritis |
Q24684755 | Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy |
Q37380147 | Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis |
Q78766803 | T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis |
Q41089801 | T cell receptor beta gene polymorphism and rheumatoid arthritis |
Q40787117 | T cell repertoire and autoimmune diseases |
Q36367545 | T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis |
Q43110424 | T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice |
Q77118268 | T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis |
Q41452516 | T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? |
Q34344632 | TCR peptide therapy in human autoimmune diseases |
Q39818926 | TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis. |
Q73783339 | TCRB clonotypes are present in CD4+ T cell populations prepared directly from rheumatoid synovium |
Q36217430 | TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation |
Q34119549 | Tachykinin receptor modulators: novel therapeutics for rheumatoid arthritis |
Q37754481 | Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials |
Q42136487 | Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes |
Q40461256 | Tenidap |
Q74404685 | Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells |
Q73128904 | Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis |
Q35336802 | The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug |
Q42221977 | The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients. |
Q28066700 | The CB2 receptor and its role as a regulator of inflammation |
Q57232115 | The Effect of Azathioprine on Serum Levels of Interleukin 6 and Soluble Interleukin 2 Receptor |
Q48159281 | The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation |
Q58799982 | The Micro-RNA Expression Profiles of Autoimmune Arthritis Reveal Novel Biomarkers of the Disease and Therapeutic Response |
Q84444178 | The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population |
Q71985615 | The Role of T‐Cell Receptor β Chain Genes in the Susceptibility to Rheumatoid Arthritis |
Q40341872 | The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium |
Q45779383 | The absence of antibodies to malaria and human immunodeficiency virus, and the presence of hepatitis B surface antigen as diagnostic markers of rheumatoid arthritis |
Q31132502 | The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis |
Q79702562 | The arthritis severity quantitative trait locus Cia7 regulates neutrophil migration into inflammatory sites |
Q57330610 | The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update |
Q53519868 | The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients. |
Q40304964 | The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis |
Q38040749 | The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications |
Q87036534 | The dynamics of aging: Measurement and intervention issues for health and function |
Q35501083 | The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis |
Q39488467 | The effectiveness of topically applied capsaicin. A meta-analysis. |
Q37754083 | The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials |
Q53107519 | The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis. |
Q38342712 | The immediate-early gene product MAD-3/EDG-3/IkappaB alpha is an endogenous modulator of fibroblast growth factor-1 (FGF-1) dependent human endothelial cell growth. |
Q38069473 | The importance of rheumatology biologic registries in Latin America |
Q67466174 | The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium |
Q36079214 | The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal |
Q38556925 | The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms |
Q36224586 | The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model |
Q40729411 | The role of adhesion molecules in the pathogenesis of rheumatoid arthritis |
Q35233166 | The role of cytokines and their inhibitors in arthritis |
Q34981650 | The role of matrix metalloproteinases in vascular disease |
Q37430478 | The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis. |
Q42129662 | The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts |
Q35107327 | The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNFα agent treatment in patients with rheumatoid arthritis: a meta-analysis. |
Q53619316 | The therapeutic potential of PDE4 inhibitors. |
Q71889641 | The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice |
Q41465945 | The use of biologics in the treatment of rheumatoid arthritis (RA)--the good news and the bad news |
Q53092577 | The usefulness of the Simplified Erosion Narrowing Score (SENS) in clinical practice for estimating joint damage in early rheumatoid arthritis. |
Q40174460 | Therapeutic effect of dimethyl dimethoxy biphenyl dicarboxylate on collagen-induced arthritis in rats. |
Q36813399 | Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice |
Q43864219 | Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. |
Q64247906 | Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies |
Q38285827 | Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy |
Q36515498 | Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy |
Q47644841 | Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis |
Q42476601 | Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1 |
Q42452643 | Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes |
Q35764161 | Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints |
Q24564656 | Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis |
Q71707157 | Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease |
Q35555894 | Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate |
Q45153959 | Treatment of rheumatoid arthritis in the third millennium |
Q33782376 | Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist |
Q33946522 | Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab |
Q80250825 | Trisomy 7 in synovial fluid cells of patients with rheumatoid arthritis |
Q74628468 | Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells |
Q40799721 | Tumour necrosis factor: a specific trigger in arthritis |
Q33536197 | Tyrosine phosphorylated proteins in synovial cells of rheumatoid arthritis |
Q40465721 | T‐Cell Receptor Use in Early Rheumatoid Arthritisa |
Q38888149 | Understanding the Regulatory Roles of Natural Killer T Cells in Rheumatoid Arthritis: T Helper Cell Differentiation Dependent or Independent? |
Q43993761 | Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase |
Q73690325 | Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions |
Q37000165 | Use of biologics in rheumatoid arthritis: current and emerging paradigms of care |
Q81881480 | Use of tissue Doppler and its comparison with other conventional Doppler techniques in the assessment of diastolic functions in patients with active rheumatoid arthritis |
Q38350992 | VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders |
Q24793818 | VLA-4-dependent and -independent pathways in cell contact-induced proinflammatory cytokine production by synovial nurse-like cells from rheumatoid arthritis patients |
Q43800675 | Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts |
Q45783315 | Virus or a hapten-carrier complex can activate autoreactive B cells by providing linked T help. |
Q37117517 | Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis |
Q95811050 | [Classification of ocular surface disease. Part 1] |
Q81772562 | [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases] |
Q73969049 | [Production of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages from patients with rheumatoid arthritis and interstitial pulmonary disease] |
Q83310999 | [Radiological differential diagnosis of rheumatoid arthritis] |
Q28115693 | cDNA Sequence and mRNA Tissue Distribution of a Novel Human Matrix Metalloproteinase with a Potential Transmembrane Segment |
Q42715792 | p53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes |
Search more.